Albert Selva-O’Callaghan

13.0k total citations · 1 hit paper
188 papers, 5.3k citations indexed

About

Albert Selva-O’Callaghan is a scholar working on Epidemiology, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, Albert Selva-O’Callaghan has authored 188 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Epidemiology, 67 papers in Rheumatology and 48 papers in Pathology and Forensic Medicine. Recurrent topics in Albert Selva-O’Callaghan's work include Inflammatory Myopathies and Dermatomyositis (103 papers), Eosinophilic Disorders and Syndromes (41 papers) and Systemic Sclerosis and Related Diseases (40 papers). Albert Selva-O’Callaghan is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (103 papers), Eosinophilic Disorders and Syndromes (41 papers) and Systemic Sclerosis and Related Diseases (40 papers). Albert Selva-O’Callaghan collaborates with scholars based in Spain, United States and Palestinian Territory. Albert Selva-O’Callaghan's co-authors include Ernesto Trallero‐Araguás, Miquel Vilardell‐Tarrés, Iago Pinal‐Fernandez, Josep M. Grau‐Junyent, Moisés Labrador‐Horrillo, Xavier Martínez‐Gómez, José C. Milisenda, Carmen Pilar Simeón‐Aznar, M Vilardell and Roser Soláns-Laqué and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Albert Selva-O’Callaghan

171 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Classification and management of adult inflammatory myopathies

2018 271 citations Albert Selva-O’Callaghan, Iago Pinal‐Fernandez et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Albert Selva-O’Callaghan Spain	37	2.9k	2.4k	1.1k	971	826	188	5.3k
Rohit Aggarwal United States	36	3.1k 1.1×	2.1k 0.9×	752 0.7×	790 0.8×	781 0.9×	168	5.3k
Pilar Brito‐Zerón Spain	47	1.4k 0.5×	3.3k 1.4×	1.1k 1.1×	909 0.9×	716 0.9×	120	8.8k
Ulrich A. Walker Switzerland	42	1.3k 0.4×	1.1k 0.5×	1.1k 1.0×	2.3k 2.4×	1.4k 1.7×	167	6.5k
Alexandre E. Voskuyl Netherlands	50	800 0.3×	5.6k 2.3×	1.2k 1.1×	1.6k 1.6×	1.0k 1.2×	246	9.2k
T. Papo France	44	990 0.3×	2.1k 0.9×	1.5k 1.4×	624 0.6×	835 1.0×	245	6.4k
Sindhu R. Johnson Canada	44	667 0.2×	1.9k 0.8×	1.4k 1.3×	1.9k 2.0×	358 0.4×	156	5.5k
Jacques‐Eric Gottenberg France	46	719 0.2×	2.7k 1.1×	520 0.5×	1.0k 1.1×	1.0k 1.3×	163	7.1k
Zachary S. Wallace United States	35	2.6k 0.9×	4.0k 1.7×	801 0.8×	277 0.3×	741 0.9×	153	5.7k
Gabriele Valentini Italy	44	1.4k 0.5×	1.8k 0.7×	1.6k 1.5×	4.3k 4.4×	798 1.0×	232	6.8k
Ricardo Blanco Spain	49	766 0.3×	6.0k 2.5×	2.9k 2.8×	769 0.8×	1.3k 1.6×	461	10.1k

Countries citing papers authored by Albert Selva-O’Callaghan

Since Specialization

Citations

This map shows the geographic impact of Albert Selva-O’Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Selva-O’Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Selva-O’Callaghan more than expected).

Fields of papers citing papers by Albert Selva-O’Callaghan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Selva-O’Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Selva-O’Callaghan. The network helps show where Albert Selva-O’Callaghan may publish in the future.

Co-authorship network of co-authors of Albert Selva-O’Callaghan

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Selva-O’Callaghan. A scholar is included among the top collaborators of Albert Selva-O’Callaghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Selva-O’Callaghan. Albert Selva-O’Callaghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Selva-O’Callaghan, Albert, Ernesto Trallero‐Araguás, & Albert Gil‐Vila. (2025). Miopatía inflamatoria idiopática. Medicina Clínica. 164(8). 429–436.

Ros, Javier, Albert Gil‐Vila, Debayan Datta, et al.. (2025). Frequent genetic alterations in myositis autoantigen genes in cancer-associated dermatomyositis. Annals of the Rheumatic Diseases. 85(3). 519–533.

Pak, Katherine, Iago Pinal‐Fernandez, María Casal-Domínguez, et al.. (2025). Myositis-specific autoantibodies recognising Mi2 also target the AIRE protein at a shared PHD zinc finger. Annals of the Rheumatic Diseases. 85(2). 351–359. 1 indexed citations

Gil‐Vila, Albert, et al.. (2024). Subclinical myocardial involvement in a cohort of patients with antisynthetase syndrome. Clinical and Experimental Rheumatology. 42(2). 309–315. 3 indexed citations

Dastmalchi, Maryam, Jiří Vencovský, Louise Pyndt Diederichsen, et al.. (2024). Autoantibodies and damage in patients with idiopathic inflammatory myopathies: A longitudinal multicenter study from the MYONET international network. Seminars in Arthritis and Rheumatism. 68. 152529–152529. 3 indexed citations

Selva-O’Callaghan, Albert, et al.. (2023). Anti-nuclear valosin-containing protein-like autoantibody is associated with calcinosis and higher risk of cancer in systemic sclerosis. Lara D. Veeken. 63(8). 2278–2283. 7 indexed citations

Rodríguez, M. López, Alberto Rivera, Albert Selva-O’Callaghan, et al.. (2023). Screening for late-onset Pompe disease in Internal Medicine departments in Spain. Orphanet Journal of Rare Diseases. 18(1). 256–256.

Castillo, Alfredo, Albert Selva-O’Callaghan, Gerard Espinosa, et al.. (2022). Clinico–pathological phenotypes of systemic sclerosis–associated myopathy: analysis of a large multicentre cohort. Lara D. Veeken. 62(SI). SI82–SI90. 12 indexed citations

Matas-García, Ana, José C. Milisenda, Gerard Espinosa, et al.. (2022). Gastrointestinal Involvement in Dermatomyositis. Diagnostics. 12(5). 1200–1200. 12 indexed citations

10.

Cordel, N., F. Jouen, Janine A. Lamb, et al.. (2022). Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study. Lara D. Veeken. 62(4). 1711–1715. 5 indexed citations

11.

Casal-Domínguez, María, Iago Pinal‐Fernandez, Katherine Pak, et al.. (2021). Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis‐Specific Autoantibodies. Arthritis & Rheumatology. 74(3). 508–517. 29 indexed citations

12.

Pinal‐Fernandez, Iago, Katherine Pak, Albert Gil‐Vila, et al.. (2021). Anti‐Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis. Arthritis & Rheumatology. 74(2). 358–364. 6 indexed citations

13.

Oldroyd, Alexander, Jeffrey P. Callen, Hector Chinoy, et al.. (2021). Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Lara D. Veeken. 60(11). 5483–5483. 4 indexed citations

14.

Selva-O’Callaghan, Albert, Fredeswinda Romero-Bueno, Ernesto Trallero‐Araguás, et al.. (2021). Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease. PubMed. 7(4). 319–333. 24 indexed citations

15.

Oldroyd, Alexander, Jeffrey P. Callen, Hector Chinoy, et al.. (2021). A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Lara D. Veeken. 60(6). 2615–2628. 87 indexed citations

16.

Castillo, Alfredo, Carmen Pilar Simeón‐Aznar, Vicent Fonollosa‐Pla, et al.. (2014). Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody. Seminars in Arthritis and Rheumatism. 44(3). 331–337. 37 indexed citations

17.

Cobo, Erik, Jordi Cortés, Josep‐María Ribera, et al.. (2011). Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial. BMJ. 343(nov22 2). d6783–d6783. 168 indexed citations

18.

Selva-O’Callaghan, Albert, et al.. (2005). Visión clásica de la enfermedad frente a nuevos enfoques. 15(1). 54–56. 1 indexed citations

19.

Selva-O’Callaghan, Albert, et al.. (1991). [Idiopathic inflammatory myopathy. Analysis of 31 patients].. PubMed. 189(6). 260–3. 3 indexed citations

20.

Jordana, R., Carlos Tolosa, Albert Selva-O’Callaghan, & Jaume Ordï. (1990). [Autoimmune hemolytic anemia and CREST syndrome].. PubMed. 94(19). 740–1. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact